• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

UMECLIDINIUM Drug Record

  • Summary
  • Interactions
  • Claims
  • UMECLIDINIUM chembl:CHEMBL1187833 Approved

    Alternate Names:

    UMECLIDINIUM
    GSK573719
    GSK-573719
    1-[2-(BENZYLOXY)ETHYL]-4-[HYDROXY(DIPHENYL)METHYL]-1-AZONIABICYCLO[2.2.2]OCTANE
    INCRUSE ELLIPTA®
    rxcui:1487514
    chembl:CHEMBL1187833
    chemidplus:869185-19-3
    drugbank:09076
    pubchem.compound:11519070

    Drug Info:

    (0 More Sources)

    Publications:

    Salmon et al., 2013, Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases., J. Pharmacol. Exp. Ther.
  • UMECLIDINIUM   CHRM5

    Interaction Score: 1.51

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:

    PMIDs:
    23435542


    Sources:
    TTD

  • UMECLIDINIUM   CYP2D6

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB FDA

  • TTD: Umeclidinium

    • Version: 2020.06.01

    Alternate Names:
    D00SLY TTD Drug ID

    Drug Info:

    Publications:

  • FDA: Umeclidinium

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1187833

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • PharmGKB: umeclidinium

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21